These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19395958)

  • 1. Pertussis in early infancy: disease burden and preventive strategies.
    McIntyre P; Wood N
    Curr Opin Infect Dis; 2009 Jun; 22(3):215-23. PubMed ID: 19395958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative.
    Forsyth KD; Campins-Marti M; Caro J; Cherry JD; Greenberg D; Guiso N; Heininger U; Schellekens J; Tan T; von König CH; Plotkin S;
    Clin Infect Dis; 2004 Dec; 39(12):1802-9. PubMed ID: 15578403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis in infants: preventing deaths and hospitalisations in the very young.
    Wood N; Quinn HE; McIntyre P; Elliott E
    J Paediatr Child Health; 2008 Apr; 44(4):161-5. PubMed ID: 18377367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis continues to put New Zealand's immunisation strategy to the test.
    Grant CC; Reid S
    N Z Med J; 2010 Apr; 123(1313):46-61. PubMed ID: 20581895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative.
    Forsyth K; Thisyakorn U; von König CH; Tan T; Plotkin S;
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):699-711. PubMed ID: 23077850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies.
    Lugnér AK; van der Maas N; van Boven M; Mooi FR; de Melker HE
    Vaccine; 2013 Nov; 31(46):5392-7. PubMed ID: 24075918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pertussis in the Netherlands].
    de Greeff SC; de Melker HE; Mooi FR
    Ned Tijdschr Geneeskd; 2010; 154():A1383. PubMed ID: 20170575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal pertussis, cocooning and maternal immunization.
    Swamy GK; Wheeler SM
    Expert Rev Vaccines; 2014 Sep; 13(9):1107-14. PubMed ID: 25075629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.
    Wiley KE; Zuo Y; Macartney KK; McIntyre PB
    Vaccine; 2013 Jan; 31(4):618-25. PubMed ID: 23200883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.
    Luz PM; Codeço CT; Werneck GL; Struchiner CJ
    Epidemiol Infect; 2006 Aug; 134(4):850-62. PubMed ID: 16316489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit of the introduction of new strategies for vaccination against pertussis in Spain: cocooning and pregnant vaccination strategies.
    Fernández-Cano MI; Armadans Gil L; Campins Martí M
    Vaccine; 2015 May; 33(19):2213-2220. PubMed ID: 25825331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands.
    Westra TA; de Vries R; Tamminga JJ; Sauboin CJ; Postma MJ
    Clin Ther; 2010 Aug; 32(8):1479-95. PubMed ID: 20728761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization.
    Skowronski DM; Janjua NZ; Tsafack EP; Ouakki M; Hoang L; De Serres G
    Clin Infect Dis; 2012 Feb; 54(3):318-27. PubMed ID: 22156850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.
    de Greeff SC; de Melker HE; Westerhof A; Schellekens JF; Mooi FR; van Boven M
    Epidemiology; 2012 Nov; 23(6):852-60. PubMed ID: 23018969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and prevention of pertussis infection in neonates.
    Berti E; Venturini E; Galli L; de Martino M; Chiappini E
    Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1515-31. PubMed ID: 25371322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.